 BURLINGTON, Mass., Feb. 17, 2021 GLOBE NEWSWIRE -- scPharmaceuticals Inc. Nasdaq: SCPH, a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced the appointment of William T. Abraham, M.D., to the companys Board of Directors. Dr. Abraham currently serves as Professor of Internal Medicine Cardiology, Physiology and Cell Biology and College of Medicine Distinguished Professor at The Ohio State University as well as Chief Medical Officer at V-Wave Ltd., a privately held developer of percutaneous implantable therapeutic devices for chronic heart failure patients. 